GMO: Buyback ends near ¥30bn cap after October purchases

GMO completed its share repurchase on Oct. 29. The resolution set the following limits, alongside cumulative results:

• Share limit: 16 million shares, equal to 16.32% of issued shares excluding treasury shares
• Purchase price cap: ¥30 billion. Cumulative spending was ¥29,999,716,700
• Method: Market purchases on the Tokyo Stock Exchange

Cumulative shares acquired remained below the limit, while spending came close to the cap. The buyback ended before the resolution period expired, with the monetary allocation effectively used up.

GMO has made the acquisition and cancellation of shares it issued in the past part of its long-term shareholder return policy. It plans to continue pursuing its long-term acquisition and cancellation goals.

• Acquisition progress: About 28.62 million shares acquired toward a target of about 38.35 million, a 74.6% completion rate
• Cancellation progress: About 10.45 million shares canceled, a 27.3% completion rate

The end of this buyback does not mean the broader long-term goals have been completed. Acquisitions and cancellations remain at different stages, making the treatment of repurchased shares another point to watch in GMO’s future shareholder returns.